| | |
ASPsiRNA information |
siRNA Id: | aspsirna0799
|
siRNA Name: | P910b
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | GUCGUCGUCGUCGUCGUCG
|
ASP-siRNA (As strand 3'->5'): | GUCGUCGUCAACGUCGUCG
|
Mismatch position in siRNA: | A9U,A10G(as) |
Gene Information |
Gene Name | Hungtintin (HTT) |
Target Sequence (5'->3'): | CAGCAGCAGCAGCAGCAGCAGCAGCAGC
|
Wild allele (5'->3'): | CAGCAGCAGCAGCAGCAGC
|
Mutant allele (5'->3'): | CAGCAGCAGCAGCAGCAGC
|
Position of siRNA on target gene: | 368-386
|
Respective Gene/Protein Resources |
GenBank Accession: | NM_002111.7 |
Cytogenic location: | 4p16.3 |
Chromosomal coordinates: | 4:3,076,407-3,245,686 |
UniProt ID: | Q96CV9 |
HUGO ID: | 4851 |
Reference SNp(RefSNP): | rs19392295 |
Disease/Mutation information |
Target Mutation: | c.52CAG(36_39)
|
Matation type/variant: | Microsatellite
|
Mutation at gene level: | NG_009378.1:g.5197CAG(36_39)
|
Pathogenic status of mutation: | Pathogenic
|
Disease: | Huntington disease (HD) |
Clinical Resources |
ClinVar ID: | 31916 |
KEGG disease ID: | H00059 |
OMIM ID: | 143100 |
COSMIC: | HTT |
DECIPHER: | HTT |
GeneTests: | HTT |
ASP siRNA details |
Mutant allele (5'->3'): | CAGCAGCAGCAGCAGCAGC
|
ASP-siRNA (As strand 3'->5'): | GUCGUCGUCAACGUCGUCG
|
Percentage efficacy of ASP-siRNA for mutant allele: | 78
|
Wild allele (5'->3'): | CAGCAGCAGCAGCAGCAGC
|
ASP-siRNA (As strand 3'->5'): | GUCGUCGUCAACGUCGUCG
|
Percentage efficacy of ASP-siRNA for wild allele: | 20
|
Relative difference: | 58
|
Wild siRNA details |
Wild allele (5'->3'): | CAGCAGCAGCAGCAGCAGC
|
Wild siRNA (As strand 3'->5'): | GUCGUCGUCGUCGUCGUCG
|
Percentage efficacy of wild siRNA for wild allele: | 72
|
Wild allele (5'->3'): | CAGCAGCAGCAGCAGCAGC
|
ASP-siRNA (As strand 3'->5'): | GUCGUCGUCAACGUCGUCG
|
Percentage efficacy of Wild sirna for mutant allele: | 50
|
Relative difference : | 22
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | Fibroblast |
Experimental technique used: | Western blot |
Transfection method: | RNAiMAX |
siRNA expression method: | Integrated DNA Technologies |
Post-transfection duration: | 72 hours |
Concentration used: | 25nM |
Reference: | 21095568 |
Delivery method: | Electroporation |
'Article title: | Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism. |
'Authors: | Hu J, Liu J, Corey DR. |
'Journal Reference: | Chem Biol. 2010 Nov 24;17(11):1183-8. doi: 10.1016/j.chembiol.2010.10.013. |
'